D. Dumoulin

Statin treatment improves response to anti-PD1 agents in patients with malignant pleural mesothelioma and non-small cell lung cancer.

J. Aerts, R. Berardi, L. Cantini, 2020, Journal of Clinical Oncology.

Atypical B cells (CD21-CD27-IgD-) correlate with lack of response to checkpoint inhibitor therapy in NSCLC.

M. Willemsen, R. Belderbos, D. Dumoulin, 2023, European journal of cancer.